Bryostatin-1 analog (Aphios Corporation)

N/A

Report date: 2026/03/06 20:02:51
NME

Base Information

Drug NameBryostatin-1 analog (Aphios Corporation)
Drug Alias NameBryostatin 1-containing phospholipid nanosomes (Bryosomes™)Nanoencapsulated APH 0703APH-1104APH-0703
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha secretases modulatorsProtein kinase C stimulants
TargetsAlpha secretasesProtein kinase C
Therapy Area/IndicationsCognition DisordersAlzheimer DiseaseCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAphios Corporation
China Registration ClassN/A

Develop Information

Active CompaniesAphios Corporation
Inactive CompaniesN/A
Active IndicationsCognition DisordersAlzheimer DiseaseCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A